All Posts Tagged With: "MRK"
(XLF) Stock Market News for August 9, 2011 – Market News
Standard & Poor’s downgraded the US credit rating by a notch, delivering a crushing blow to benchmarks on Monday. Tension from the other side of the Atlantic also dampened sentiment as Europe was gripped by debt woes. Investors also struggled to find a clear answer about...
(AMGN) Company News for August 1, 2011 – Corporate Summary
• Chevron Corp. (NYSE:CVX) reported a jump in its second-quarter 2011 profits, benefiting from higher oil prices and stronger refining margins. Earnings per share (excluding adjustments for foreign-currency effects)...
(AMGN) Debt Ceiling Debate and Dismal GDP Add To Market Stress
The debt debate continues to steal the spotlight from earnings and economic reports. The stock market has lost ground in recent days due to this uncertain environment even as corporate earnings reports have broadly come ahead of expectations.
With both sides in the...
(AMGN) Amgen Beats Earnings Expectations – Updates Outlook
Amgen (AMGN) reported second quarter earnings per share of $1.35, 5 cents above the Zacks Consensus Estimate and 0.7% above the year-ago earnings. Total revenues increased 4% to $3,959 million in the second...
(XLF) Stock Market News for July 19, 2011 – Market News
Lingering euro-zone debt worries and the impasse over debt-ceiling negotiations weighed down investor sentiment on Monday, while bank shares felt the burn of the markets’ downtrend.
The Dow Jones Industrial Average (DJIA) shed 0.8% to close at 12,385.16. The Standard...
(MRK) Japanese Approval for Merck Products
Merck (MRK) recently announced that it received approval for three products in Japan. The Japanese Ministry of Health, Labour and Welfare (MHLW) approved Gardasil [human papillomavirus quadrivalent (Types...
(MHS) Medco Health Solutions to Better Tackle Hepatitis C
Medco Health Solutions (MHS) is making attempts to curtail costs of treating patients suffering from hepatitis C (HCV). The company’s specialty pharmacy segment, Accredo Health Group, considers patient adherence...
(AAPL) Company News for July 5, 2011 – Corporate Summary
• Eastman Kodak Co. (NYSE:EK) received a mixed ruling from the U.S. International Trade Commission on its patent infringement suit against Research In Motion Limited (NASDAQ:
5Jul2011 | vitalstocks | 0 comments | Continued(UPS) UPS-Merck Expand Deal
United Parcel Services (UPS), the world’s largest package delivery company, inked a new deal with healthcare giant Merck & Co. Inc. (
29Jun2011 | vitalstocks | 0 comments | Continued(NVO) Novo Nordisk Presents Diabetes Study Data
Recently, Novo Nordisk (NVO) presented data from two extension studies of its lead diabetes drug Victoza at the American Diabetes Association. Victoza is currently marketed as a once-daily human Glucagon-Like...
(ABT) Abbott Labs Boosts Immunology Pipeline
Abbott Labs (ABT) recently entered into a global agreement with Biotest AG for the development and commercialization of a novel anti-CD4 antibody, BT-061.
The Candidate: BT-061
The...
(VRTX) Vertex Pharmaceuticals Get Positive Data on Incivek
Vertex Pharmaceuticals Inc. (VRTX) recently reported data from two late stage trials – ADVANCE and REALIZE – on Incivek (telaprevir). The data were published in the June edition of the New England...
(JNJ) Pharma & Biotech Stock Outlook – June 2011 – Industry Outlook
Challenges like sluggish prescription trends, EU pricing pressure, intensifying generic competition, pipeline failures and limited late-stage catalysts continue to impact the pharmaceutical industry. The next five years are expected to reflect a significant imbalance between...
(PRGO) Perrigo Cruises Past Estimates – Lifts Outlook
Perrigo Company (PRGO) reported earnings per share of $1.07 for the third quarter of fiscal 2011, easily beating the Zacks Consensus Estimate of 96 cents and the year-earlier earnings of 81 cents per share....
(AZN) AstraZeneca Revenues Fall – Outlook Improves
AstraZeneca plc (AZN) reported first-quarter fiscal 2011 core earnings of $2.23 per American Depositary Share (ADS), reflecting an increase of 10% (at constant exchange rates [CER]) from the prior-year quarter....
(CAG) Company News for May 2, 2011 – Corporate Summary
• Research firm Argus downgraded Flextronics International Ltd. (NASDAQ:FLEX) from “buy” to “hold” rating
2May2011 | vitalstocks | 0 comments | Continued(AXP) Stock Market News for May 2, 2011 – Market News
Investors were in an upbeat mood after the benchmarks had their best monthly performance in years and the markets had their best run in five weeks, ended with gains on Friday. Through the week, the indices were pushed higher by the Federal Reserve’s vow to keep interest...
(AMGN) Amgen Beats First Quarter Estimates – Maintains Outlook
Amgen (AMGN) reported first quarter earnings per share of $1.32, 3 cents above the Zacks Consensus Estimate of $1.29 and 3.1% above year-ago earnings. Higher revenues, a lower tax rate and lower share count...
(MRK) Five Large Cap Pharmaceuticals to Consider
The Large Cap Pharma sector is the fastest rising sector on Barchart when screening for the 1 month price change. The general investing public is very interested in this sector as evidenced by the 25,409 opinions expressed on Motley Fool on the 5 stocks I selected. Before...
(ALKS) Company News for April 18, 2011 – Corporate Summary
• Chesapeake Energy Corp’s. (NYSE:CHK) share prices gained 0.25% after it announced plans to buy Bronco Drilling Co. (NASDAQ:BRNC) for $11 a share. The purchase...
(KR) Consumer Price Index – Core Inflation Running 2.7% Annualized
The Consumer Price Index (CPI) rose by 0.5% in March, matching its rise in February, and after 0.4% increases in both January and December. While that sounds bad, year over year it is up just 2.7%.
Beneath the Headline Numbers
Looking...
(MRK) Merck’s Cancer Drug Earns US Food and Drug Administration Clearance
Recently, the US Food and Drug Administration (FDA) cleared Merck & Co., Inc.’s (MRK) skin cancer (melanoma) drug, Sylatron (peginterferon alfa-2b). The once-weekly injectable drug has been approved...
(MNKD) MannKind Corporation’s Afrezza Drug Gets Good News
There was some good news for MannKind Corporation’s (MNKD) lead pipeline candidate, Afrezza, when the US Food and Drug Administration (FDA) rescheduled its end-of-review meeting with the company to discuss...
(MRK) Merck in Joint Venture with Sun Pharma
Merck & Co., Inc. (MRK) recently announced that it is setting up a joint venture (JV) with Indian multinational pharma company, Sun Pharmaceutical Industries Ltd. The joint venture is for the development,...
(ENZN) Enzon Pharmaceuticals Analyst Holds Shares at Neutral
We have maintained our Neutral recommendation on Enzon Pharmaceuticals, Inc. (ENZN) with a target price of $12.00 after announcement of fourth quarter and full year 2010 results.
Enzon Pharmaceuticals’...
(KR) Core Consumer Price Index Inflation Still Tame
The Consumer Price Index (CPI) rose by 0.5% in February, up from a 0.4% increase in both January and December. While that sounds bad, year over year it is up just 2.1%. Looking a little bit deeper, the problem is mostly with energy, and to a lesser extent,...
(KR) Consumer Price Index Increases but Still Tame
The Consumer Price Index (CPI) rose by 0.4% in January, The same pace as in December (after December was revised down to 0.4% from 0.5%). The CPI increased by just 0.1% in November, so the past two months are a bit of an acceleration. While that sounds bad,...
(MNKD) MannKind Fourth Quarter Reports Smaller-than-Anticipated Loss
MannKind Corporation’s (MNKD) fourth quarter 2010 net loss of $0.33 per share was narrower than the Zacks Consensus Estimate of a loss of $0.40. The company had suffered a loss of $0.41 (excluding the loss...
(BJ) Stock Market News for February 04, 2011 – Market News
Markets closed in the green on Thursday after reports of strong sales posted by retailers for January and other positive economic data sparked a rally. However, the gains were limited by mixed earnings reports and worries about the situation in the Egypt.
(AA) Stock Market News for January 14, 2011 – Market News
On Thursday, markets ended marginally lower and shed gains from the previous session. The dismal show of the indices yesterday was primarily due to disappointing economic data. However, successful bond auctions in Europe somewhat soothed investors’ frayed nerves.